Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cell composition comprising liver progenitor cells expressing hla-e

A technology of HLA-E and composition, applied in the direction of liver cells, drug combinations, animal cells, etc., can solve the problems of not disclosing liver stem cells or progenitor cell populations, not mentioning HLA-E expression, etc., to increase efficacy and safety Sexual, potentiated immunosuppressive and/or immune-evading properties

Pending Publication Date: 2021-08-27
PROMETHERA THERAPEUTICS SA
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] None of these prior art documents disclose the need to obtain a population of HLA-E expressing hepatic stem or progenitor cells for clinical use, nor does it mention that sufficient HLA-E expression may play a role in evading cytolysis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cell composition comprising liver progenitor cells expressing hla-e
  • Cell composition comprising liver progenitor cells expressing hla-e
  • Cell composition comprising liver progenitor cells expressing hla-e

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0207] 1. Preparation of pretreated HLA-E positive hepatic progenitor cells or stem cells

[0208] (a) Preparation of hepatic progenitor cells

[0209] Human adult hepatic progenitor cells were isolated from the liver of healthy cadaver or beating donors as described in EP3140393 or WO2017149059.

[0210] Briefly, hepatocyte preparations were resuspended in Williams'E medium supplemented with 10% FBS, 10 mg / ml INS, 1 mM DEX. primary cells in Flasks were cultured at 37°C in 5% CO 2 cultured in a completely humid atmosphere. After 24 hours, the medium was changed to eliminate non-adherent cells, and refreshed twice a week thereafter, and the cultures were observed daily under the microscope. After 12-16 days, change the medium to high glucose DMEM supplemented with 9% FBS. Cell types with mesenchymal-like morphology emerge and proliferate. When reaching 70-95% confluence, cells were trypsinized with recombinant trypsin and 1 mM EDTA and incubated at 1-10 x 10 3 cells / c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The current invention concerns isolated liver progenitor cells, cell lines thereof, cell populations comprising such and compositions comprising such wherein the liver progenitor cells are HLA-E positive. In addition, the invention concerns methods of preparing these liver progenitor cells.

Description

technical field [0001] The technical field to which the present invention pertains is isolated hepatic progenitor or stem cells derived from the liver and their use in medicine, hepatology, transplantation, liver failure and fibroinflammatory liver disease. Background technique [0002] The liver is a key organ that performs many important functions. Impairment of one of several liver functions can have significant health consequences. The global incidence of acute or chronic liver disease makes these conditions the fifth to ninth leading cause of death according to the World Health Organization. Liver cell transplantation (LCT) is an ongoing clinical investigation procedure for the treatment of liver disease with the goal of liver repair / regeneration (Najimi et al, Stem Cells Translational Medicine, 2016). Despite efforts to make the donor as closely as possible immunologically matched to the recipient, issues related to immune system rejection after hepatocyte transplant...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/071
CPCC12N5/0672C12N2501/2301C12N2501/231C12N2501/24C12N2501/25A61K35/407A61P1/16
Inventor J-L·齐林格里安E·科里托雷G·马扎N·贝尔蒙特E·索卡尔
Owner PROMETHERA THERAPEUTICS SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com